Cargando…

3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions

We designed a novel 6-point electrochemical impedance spectroscopy (EIS) sensor with 15 combinations of permutations for the 3-D mapping and detection of metabolically active atherosclerotic lesions. Two rows of 3 stretchable electrodes circumferentially separated by 120° were mounted on an inflatab...

Descripción completa

Detalles Bibliográficos
Autores principales: Packard, René R. Sevag, Luo, Yuan, Abiri, Parinaz, Jen, Nelson, Aksoy, Olcay, Suh, William M., Tai, Yu-Chong, Hsiai, Tzung K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525747/
https://www.ncbi.nlm.nih.gov/pubmed/28744325
http://dx.doi.org/10.7150/thno.19184
_version_ 1783252696648646656
author Packard, René R. Sevag
Luo, Yuan
Abiri, Parinaz
Jen, Nelson
Aksoy, Olcay
Suh, William M.
Tai, Yu-Chong
Hsiai, Tzung K.
author_facet Packard, René R. Sevag
Luo, Yuan
Abiri, Parinaz
Jen, Nelson
Aksoy, Olcay
Suh, William M.
Tai, Yu-Chong
Hsiai, Tzung K.
author_sort Packard, René R. Sevag
collection PubMed
description We designed a novel 6-point electrochemical impedance spectroscopy (EIS) sensor with 15 combinations of permutations for the 3-D mapping and detection of metabolically active atherosclerotic lesions. Two rows of 3 stretchable electrodes circumferentially separated by 120° were mounted on an inflatable balloon for intravascular deployment and endoluminal interrogation. The configuration and 15 permutations of 2-point EIS electrodes allowed for deep arterial penetration via alternating current (AC) to detect varying degrees of lipid burden with distinct impedance profiles (Ω). By virtue of the distinctive impedimetric signature of metabolically active atherosclerotic lesions, a detailed impedance map was acquired, with the 15 EIS permutations uncovering early stages of disease characterized by fatty streak lipid accumulation in the New Zealand White rabbit model of atherosclerosis. Both the equivalent circuit and statistical analyses corroborated the 3-D EIS permutations to detect small, angiographically invisible, lipid-rich lesions, with translational implications for early atherosclerotic disease detection and prevention of acute coronary syndromes or strokes.
format Online
Article
Text
id pubmed-5525747
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-55257472017-07-25 3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions Packard, René R. Sevag Luo, Yuan Abiri, Parinaz Jen, Nelson Aksoy, Olcay Suh, William M. Tai, Yu-Chong Hsiai, Tzung K. Theranostics Research Paper We designed a novel 6-point electrochemical impedance spectroscopy (EIS) sensor with 15 combinations of permutations for the 3-D mapping and detection of metabolically active atherosclerotic lesions. Two rows of 3 stretchable electrodes circumferentially separated by 120° were mounted on an inflatable balloon for intravascular deployment and endoluminal interrogation. The configuration and 15 permutations of 2-point EIS electrodes allowed for deep arterial penetration via alternating current (AC) to detect varying degrees of lipid burden with distinct impedance profiles (Ω). By virtue of the distinctive impedimetric signature of metabolically active atherosclerotic lesions, a detailed impedance map was acquired, with the 15 EIS permutations uncovering early stages of disease characterized by fatty streak lipid accumulation in the New Zealand White rabbit model of atherosclerosis. Both the equivalent circuit and statistical analyses corroborated the 3-D EIS permutations to detect small, angiographically invisible, lipid-rich lesions, with translational implications for early atherosclerotic disease detection and prevention of acute coronary syndromes or strokes. Ivyspring International Publisher 2017-06-22 /pmc/articles/PMC5525747/ /pubmed/28744325 http://dx.doi.org/10.7150/thno.19184 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Packard, René R. Sevag
Luo, Yuan
Abiri, Parinaz
Jen, Nelson
Aksoy, Olcay
Suh, William M.
Tai, Yu-Chong
Hsiai, Tzung K.
3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions
title 3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions
title_full 3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions
title_fullStr 3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions
title_full_unstemmed 3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions
title_short 3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions
title_sort 3-d electrochemical impedance spectroscopy mapping of arteries to detect metabolically active but angiographically invisible atherosclerotic lesions
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525747/
https://www.ncbi.nlm.nih.gov/pubmed/28744325
http://dx.doi.org/10.7150/thno.19184
work_keys_str_mv AT packardrenersevag 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions
AT luoyuan 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions
AT abiriparinaz 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions
AT jennelson 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions
AT aksoyolcay 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions
AT suhwilliamm 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions
AT taiyuchong 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions
AT hsiaitzungk 3delectrochemicalimpedancespectroscopymappingofarteriestodetectmetabolicallyactivebutangiographicallyinvisibleatheroscleroticlesions